NASDAQ:OTLK | Insider Transactions — Page 2 | Outlook Therapeutics, Inc.

OTLK Insider Transactions — Page 2

106 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–106; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Mohan PankajPresident & CEO2017-12-18Sale20,523.0$1.17
Yamashita Elizabeth A.VP, Regulatory Affairs2017-12-18Sale1,509.0$1.17
Griffith Donald J.Director2016-11-23Sale1.0$3.75
Gangloff Scott A.SVP, Development & Mfrg2016-11-11Sale37,369.0$3.75
MCANDREW STEPHEN JSVP Bus. Strat. & Dev.2016-11-11Sale21,367.0$3.75
Bahrt KennethChief Medical Officer2016-05-13Purchase2,000.0